Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 9/20 | 0.66 |
| ▸ | MGAM | O43451 | 4/20 | 0.66 |
| ▸ | GBA1 | P04062 | 4/20 | 0.66 |
| ▸ | SI | P14410 | 3/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.66 |
| ▸ | LCT | P09848 | 1/20 | 0.66 |
| ▸ | GBA2 | Q9HCG7 | 11/20 | 0.58 |
| ▸ | UGCG | Q16739 | 3/20 | 0.58 |
| ▸ | AGL | P35573 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17128702 | 0.84 | GAA (0.72) | GAAMGAMGBA1SITDP1 | |
| SCHEMBL2270637 | 0.83 | GAA (0.70) | GAAMGAMGBA1SITDP1 | |
| SCHEMBL26679472 | 0.83 | GAA (0.70) | GAAMGAMGBA1SITDP1 | |
| SCHEMBL2274019 | 0.81 | GAA (0.68) | GAAMGAMGBA1SITDP1 | |
| SCHEMBL23503288 | 0.79 | GAA (1.00) | GAAMGAMGBA1SITDP1 | |
| Miglitol SCHEMBL22593 | 0.79 | GAA (1.00) | GAAMGAMGBA1SITDP1 | |
| SCHEMBL3378972 | 0.79 | GAA (0.66) | GAAMGAMGBA1SITDP1 | |
| SCHEMBL23503369 | 0.79 | GAA (1.00) | GAAMGAMGBA1SITDP1 | |
| Miglitol SCHEMBL9207953 | 0.79 | GAA (1.00) | GAAMGAMGBA1SITDP1 | |
| Miglitol SCHEMBL23892585 | 0.79 | GAA (1.00) | GAAMGAMGBA1SITDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9150557-B1 | Compositions and methods for the treatment of hyperglycemia | CELLIX BIO PRIVATE LIMITED (IN) | 2015-10-06 | — | — | US | claimed |